AveXis is a clinical-stage gene therapy company developing innovative treatments for rare and life-threatening genetic diseases.    Its initial product candidate is AVXS-101, a gene therapy product candidate that has completed Phase I clinical trial for the treatment of spinal muscular atrophy Type 1.
AveXis is a rapidly growing leader among gene therapy biotech companies and continues to establish relationships with academics, biotechnology and pharmaceutical companies, and healthcare investors.

Employee Rating

3.3More
TypeSubsidiary
Parent CompanyNovartis
HQBannockburn, US
Founded2010
Websiteavexis.com
AveXis was founded in 2010 and is headquartered in Bannockburn, US
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at AveXis

Sean Nolan

Sean Nolan

CEO
Phillip Donenberg

Phillip Donenberg

CFO
Sukumar Nagendran

Sukumar Nagendran

CMO
Brian Kaspar

Brian Kaspar

CSO
Rick Modi

Rick Modi

CBO
R.a. Session

R.a. Session

SVP
Show more

AveXis Office Locations

AveXis has an office in Bannockburn
Bannockburn, (HQ)
200 2275 Half Day Rd
Bannockburn, (HQ)
160 2275 Half Day Rd
Show all (2)
Report incorrect company information

AveXis Financials and Metrics

Summary Metrics

In total, AveXis had raised $75 m. AveXis is a subsidiary of Novartis

AveXis Revenue

Annual
USDFY, 2016FY, 2017

General and administrative expense

24.5m70.0m

R&D expense

58.9m150.4m

Operating expense total

83.4m220.4m

EBIT

(83.4m)(220.4m)
Quarterly
USDQ1, 2016Q2, 2016Q3, 2016Q1, 2017

Revenue

General and administrative expense

4.8m5.4m7.1m9.6m

R&D expense

16.1m10.4m14.1m20.3m

Operating expense total

20.9m15.8m21.2m30.0m
Annual
USDFY, 2016FY, 2017

Cash

240.4m324.1m

Current Assets

245.2m332.4m

PP&E

24.2m56.2m

Total Assets

270.6m391.6m
Quarterly
USDQ1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018

Cash

148.2m131.4m263.6m204.5m586.8m

Current Assets

149.7m134.4m267.5m211.7m598.4m

PP&E

5.9m8.3m16.8m33.7m62.9m

Total Assets

156.0m143.1m284.8m247.2m667.3m
Annual
USDFY, 2016FY, 2017

Net Income

(83.0m)(218.1m)

Depreciation and Amortization

64.6k2.3m

Accounts Payable

958.0k6.4m

Cash From Operating Activities

(48.0m)
Quarterly
USDQ1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018

Net Income

(20.8m)(15.7m)(21.1m)(29.7m)(222.1m)

Depreciation and Amortization

11.0k244.1k1.3m

Accounts Payable

580.7k1.1m3.7m6.5m1.7m

Cash From Operating Activities

(7.7m)(28.1m)(160.6m)
Show all financial metrics
Report incorrect company information

AveXis Online and Social Media Presence

Embed Graph
Report incorrect company information

AveXis News and Updates

Gene Therapy Market Growth Analysis Till 2025: AveXis, Vineti, Solid Biosciences., Spark Therapeutics, Inc., CHIMERON BIO, RENOVA THERAPEUTICS

Global Gene Therapy Market Analysis to 2025 is a specialized and in-depth study of the gene therapy industry with a focus on the global market trend. Posted via Industry Today. Follow us on Twitter @IndustryToday

Spinal Muscular Atrophy Market In-Depth Analysis including key players Lonis Pharmaceuticals, F. Hoffmann-La Roche, AveXis

HTF MI recently launched the Global Spinal Muscular Atrophy study with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. Posted via Industry Today. Follow us on Twitter @IndustryToday

Novartis' brand-new gene therapy player AveXis will build $55M plant, hire 200

AveXis, the gene therapy biotech Novartis snapped up for $8.7 billion, will build a new manufacturing plant in North Carolina to produce its specialized therapies.
Show more
Report incorrect company information

AveXis Company Life and Culture

Report incorrect company information

AveXis Frequently Asked Questions

  • When was AveXis founded?

    AveXis was founded in 2010.

  • Who are AveXis key executives?

    AveXis's key executives are Sean Nolan, Phillip Donenberg and Sukumar Nagendran.

  • Who are AveXis competitors?

    Competitors of AveXis include Regenxbio, Lexicon Pharmaceuticals and Illumina.

  • Where is AveXis headquarters?

    AveXis headquarters is located at 200 2275 Half Day Rd, Bannockburn.

  • Where are AveXis offices?

    AveXis has an office in Bannockburn.

  • How many offices does AveXis have?

    AveXis has 2 offices.